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ABSTRACT
Background The objective of this study is to assess the impact of dysnatraemia on mortality among intensive
care unit (ICU) patients in a large, international cohort.
Material and methods Analysis of the Extended Prevalence of Infection in Intensive Care (EPIC II) study, a 1-day
(8May 2007)worldwidemulticenter, prospective point prevalence study. Hyponatraemiawas categorized asmild
(130–134 mM/L), moderate (125–129 mM/L) or severe (< 125 mM/L). Hypernatraemia was also categorized as
mild (146–150 mM/L), moderate (151–155 mM/L) or severe (> 155 mM/L). Patients with normal serum sodium
(135–145 mM/L) constituted the reference group. The main outcome was hospital mortality. Analysis was con-
ducted separately for patients admitted on the study day (258%) and those already present on the ICU (742%).
Results Serum sodium was measured in 13 276 of the 13 796 patients (962%). A total of 3815 patients
(287%) had dysnatraemia: 129% with hyponatraemia and 158% with hypernatraemia. The prevalence of
dysnatraemia was significantly greater in patients already present on the ICU prior to the study day than for
those just admitted (131% vs. 123% for hyponatraemia and 171% vs. 121% for hypernatraemia, both
P < 0001). Hospital mortality rates were higher in patients with dysnatraemia than in those with normal sodium
levels and were directly related to the severity of hypo- and hypernatraemia. This association between dysna-
traemia and mortality was similar in infected and noninfected patients (P = 0061).
Conclusions Dysnatraemia is more frequent during the ICU stay than on the day of admission. Dysnatraemia in
the ICU – even mild – is an independent predictor of increased hospital mortality.
Keywords Hypernatraemia, hyponatraemia, intensive care, propensity score, sodium.
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Introduction
Serum sodium measurements are obtained routinely in inten-
sive care unit (ICU) patients. Dysnatraemia (hyponatraemia
and hypernatraemia) is common in these patients and has
prognostic implications, such that sodium levels have been
integrated into several severity scores [1]. Hyponatraemia is
associated with worse outcomes, particularly in patients with
congestive heart failure [2] and cirrhosis [3]. In a retrospective
database of more than 150 000 ICU patients, Funk et al. [4]
demonstrated that both hypo- and hypernatraemia present on
admission to the ICU were independent risk factors for
increased mortality. Patients were stratified into subgroups of
hypo- and hypernatraemia (borderline, mild and severe), and
even borderline dysnatraemia at admission to the ICU was an
independent risk factor for poor prognosis. Recently, Whelan
et al. [5] showed, in a cohort of more than 14 000 acute unse-
lected (emergency) general medical patients, that serum
sodium at admission was a risk factor for in-hospital mortality.
Again, even borderline hyponatraemia (130–134 mM/L) was
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associated with a worse hospital outcome. Waikar et al. [6] also
stratified a large population of unselected hospitalized adult
patients according to the degree of hyponatraemia and showed
a close relationship between hyponatraemia – even mild – and
mortality. A limitation of their study was the evaluation of a
cohort of patients over a 10-year period, during which
significant changes in diagnosis and therapy may have
occurred. In a prospective study conducted over a 14-year
period, Darmon et al. [7] also observed that dysnatraemia was
an independent risk factor for day-30 mortality. In a study of
ICU-acquired dysnatraemia, Stelfox et al. [8] showed that ICU-
acquired hypo- and hypernatraemia were associated with
increased hospital mortality, but these authors did not evaluate
the relationship between the severity of the dysnatraemia and
outcome.
We, therefore, used a large prospective database of ICU
patients [9] to evaluate whether dysnatraemia is an indepen-
dent risk factor for increased mortality in critically ill patients.
We also investigated whether the presence of infection in these
patients and the occurrence of dysnatraemia at ICU admission
or during the ICU stay impacted on outcomes.
Patients and methods
Patient selection/database
The Extended Prevalence of Infection in Intensive Care (EPIC)
II study protocol has been reported in detail previously [9].
ICUs were asked to participate in a 1-day, prospective, multi-
center point prevalence study, conducted to provide an up-
to-date picture of the extent and pattern of infection in ICUs
throughout the world (see Appendix A for list of participating
ICUs). Demographic, physiological and therapeutic data were
collected from all patients between midnight on May 7 and
midnight on 8 May 2007. The Simplified Acute Physiology
Score (SAPS) II was calculated on the study day. Data were
recorded using preprinted case report forms. Participating
ICUs were asked to provide patient follow-up until discharge
or for 60 days (until 9 July 2007), and ICU and hospital out-
comes were recorded. Participation in the EPIC II study was
entirely voluntary, and the study was not funded. For the ori-
ginal EPIC II protocol, local ethical committee approval at each
participating centre was expedited or waived owing to the
purely observational nature of the study.
Definition of categories of patients
As part of SAPS II, serum sodium was measured in every
patient on the study day (8 May 2007); in 258% of the patients,
this represented the day of ICU admission, and the remaining
742% of patients were already being treated in the ICU. We
analysed these subgroups of patients separately. Patients with
normal sodium (135–145 mM/L) values represented the refer-
ence group. Dysnatraemia was divided into hyponatraemia
(severe < 125 mM/L, moderate 125–129 mM/L and mild
130–134 mM/L) and hypernatraemia (mild 146–150 mM/L,
moderate 151–155 mM/L and severe > 155 mM/L). The cut-
offs used to divide dysnatraemia into categories were based on
those previously used in the literature in order to be able to
compare our results with previous reports [4,6,7].
Infection was defined according to the definitions of the
International Sepsis Forum [10] and adjudicated by the
attending physician.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics
20 for Windows (IBM, Armonk, NY, USA). The Kolmogorov–
Smirnov test was used, and histograms and normal quantile
plots were examined to verify whether there were significant
deviations from the normality assumption of continuous vari-
ables. Different testing between groups was performed using
analysis of variance, Kruskal–Wallis, Student’s t-test, Mann–
Whitney U-test, chi-square test or Fisher’s exact test as appro-
priate. The Bonferroni correction was made for multiple com-
parisons. Logistic regression analyses with hospital mortality as
the dependent variable were performed to determine the
mortality risk linked to dysnatraemia. To remove any bias of
confounding variables for the association between dysnatra-
emia and mortality, a propensity score for each dysnatraemia
class was estimated using multinomial logistic regression. The
following variables were considered as factors: type of admis-
sion, source of admission, comorbidities, age, sex, mechanical
ventilation, haemofiltration or haemodialysis, infection, SAPS II
score and type of microorganism. After checking that balance
on all covariates that were used in the propensity model had
been achieved, we introduced the propensity score into the
logistic regression model [11,12]. Reported odds ratios were
adjusted for propensity score, hospital and organizational
related factors, including type of ICU (closed vs. open, com-
munity vs. university, surgical vs. medical), number of ICU
beds, number of nurses, number of physiotherapists, presence
of 24-h ICU physician coverage, length of ICU stay prior to
study day and geographical region. Data are presented as mean
(95% confidence interval), median [interquartile range (IQR)] or
number (%) as appropriate. All tests were two tailed, and a
P < 005 was considered statistically significant.
Results
Characteristics of the study group
The EPIC II study included 1265 ICUs in 76 countries with
13 796 adult patients; 7087 (514%) were infected. On the study
day, serum sodium was measured in 13 276 (962%) of the
patients. Of these measurements, 9461 (713%) were within the
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Mean 586 616 601 607 619* 609 586
95% CI 554–619 595–637 591–61 603–61 611–628 593–624 563–609
Male
% 594 589 621 625 624 609 665
SAPS II
Mean 484* 386* 356* 339 412* 45* 459*
95% CI 447–52 365–406 347–364 336–342 404–42 434–465 438–48
SOFA
Mean 85* 72* 63* 59 75* 85* 89*
95% CI 69–10 65–78 6–66 58–6 73–78 8–89 84–95
Days in ICU
Median 1 2 5* 2 4* 6* 6*
25–75th
percentile
0–5 0–11 1–14 0–9 1–12 1–13 2–13
Comorbid conditions
COPD 10 (99) 42 (166) 229 (169) 1576 (167) 271 (192) 75 (168) 42 (171)
Heart failure 10 (99) 29 (115) 141 (104) 903 (95) 145 (103) 53 (119) 26 (106)
Cirrhosis 9 (89)* 18 (71)* 49 (36) 289 (3) 56 (4) 26 (58)* 2 (08)
Chronic renal
failure
8 (79) 29 (115) 128 (94) 858 (91) 134 (95) 44 (99) 22 (9)
IDDM 13 (121) 39 (154)* 136 (10) 858 (91) 188 (133)* 36 (81) 30 (122)
Solid organ
cancer
27 (267) 41 (201) 274 (201) 1765 (174) 234 (165) 90 (201) 46 (218)
Haematological
cancer
1 (1) 4 (16) 30 (22) 200 (21) 24 (17) 15 (34) 5 (2)
HIV 1 (1) 4 (16) 15 (11) 55 (06) 8 (06) 5 (11) 3 (12)




44 (44) 126 (50) 681 (501) 5037 (533) 1054 (748)* 351 (789)* 203 (829)*
Haemodialysis/
filtration
10 (101) 30 (119) 187 (138)* 879 (93) 98 (7)* 23 (52)* 14 (57)
Type of admission
Elective surgery 6 (59)* 42 (167)* 251 (185)* 2436 (258) 263 (187)* 63 (148)* 33 (135)*
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normal range; 1713 patients (129%) had hyponatraemia [1359
(793%) mild, 253 (148%) moderate and 101 (59%) severe]; and
2102 (158%) patients had hypernatraemia [1411 (671%) mild,
446 (212%) moderate and 245 (117%) severe]. Patient charac-
teristics according to the different serum sodium groups are
shown in Table 1. SAPS II and SOFA scores were significantly
higher in patients with all degrees of dysnatraemia than in
those with normal sodium levels. Hypernatraemia was more
common than normonatraemia in mechanically ventilated
patients. Patients with hypernatraemia and mild hyponatra-
emia had longer lengths of ICU stay prior to the study day than
those with normonatraemia.
Of the 13 276 measurements, 3425 (258%) were made in
patients who were admitted on the study day and 9851 (742%)
in patients who were already present in the ICU. In patients
admitted on the study day, the prevalence of hyponatraemia
(123%) and hypernatraemia (121%) was similar (P = 081),
whereas hypernatraemia was more frequent than hyponatra-
emia in patients already in the ICU (171% vs. 131%,
P < 0001).
Relation with mortality and length of stay
There were significant differences in ICU and hospital lengths
of stay among the groups of patients with dysnatraemia
(P < 0001) (Table 2). Hospital mortality rates for the different
groups also differed (Table 2), following a U-shaped pattern
(Fig. 1) with higher rates for severe dysnatraemia; hospital
mortality reached more than 50% for patients with severe
hypernatraemia. Hospital mortality rates were similar in
patients with dysnatraemia already present in the ICU
compared with those admitted on the study day both for
hyponatraemia (288% vs. 293%) and hypernatraemia (392%
vs. 353%). Adjusted ORs for hospital mortality also had a U
shape with higher values at the extreme sodium values (Fig. 2).
The association between dysnatraemia and hospital mortality
was observed in infected as well as in noninfected patients and
was not statistically different between the two groups of
patients (P = 0061) (Fig. 3).
Discussion
In this study, we investigated the frequency of dysnatraemia
and its effect on mortality in a large, mixed population of
medical and surgical patients in 1265 ICUs across 76 countries.
Dysnatraemia was common, affecting 29% of ICU patients,
and was independently associated with increased hospital
mortality.
The higher incidence of hypernatraemia in patients already
being treated in the ICU (171%) compared with newly
admitted patients (121%) is in accordance with the results of
other series [13–15]. In a retrospective monocentre study,
Lindner et al. [13] reported that the majority of cases of
hypernatraemia (defined as a serum sodium > 149 mM/L) in
the ICU developed during the ICU stay (2% hypernatraemia
on admission vs. 7% during the ICU stay). These authors did
not find a difference in mortality (39% vs. 43%) between the
two subgroups. Using a similar cut-off of serum sodium
(> 150 mM/L), the incidence of hypernatraemia in our data-
base – defined as moderate to severe hypernatraemia accord-
ing to our criteria – was 36% at admission and 57% during the
ICU stay, and we also found no significant difference in mor-
tality rates between these groups of patients (400% vs. 495%,
P = 027). In a French multicentre cohort, using the same cut-
off value of 150 mM/L, hypernatraemia was observed in 36%
of patients at ICU admission and in 147% of patients already
treated in the ICU [14]. In a recent large cohort of ICU patients,
Waite et al. [16] reported that hypernatraemia (defined as
serum Na > 149 mM/L) developed after admission in 43% of
patients and was independently associated with an increased
risk of hospital mortality [relative risk (RR) 140 (95% confi-
dence interval, 134-145)] and ICU length of stay. All these
results suggest an iatrogenic component for the hypernatra-
emia occurring during the ICU stay. Some authors have sug-
gested that the incidence of hypernatraemia in the ICU is an
indicator of the quality of care [17].
The mechanisms involved in the development of hyperna-
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Medical 56 (554)* 74 (295) 395 (292) 2567 (271) 403 (286) 145 (325) 71 (291)
Emergency
surgery
32 (317) 114 (459) 560 (413)* 3535 (374) 602 (427)* 183 (41) 104 (426)
Trauma 7 (69) 21 (84) 149 (11) 911 (96) 142 (101) 52 (117) 36 (148)
COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; IDDM, insulin-dependent diabetes mellitus; SAPS, Simplified Acute
Physiology Score.
*Statistical significance at 5% level vs. normal group.
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of free water and can be discriminated by clinical assessment
and urine electrolyte analysis [18]. Because many critically ill
patients have impaired levels of consciousness, their water
balance can no longer be regulated by thirst. This applies par-
ticularly to patients receiving mechanical ventilation, which
was associated with more frequent development of hyperna-
traemia in our cohort. In a monocentre case–control study
including 130 cases of hypernatraemia, Hoorn et al. [19]
showed that hypernatraemia was more commonly associated
with sepsis, hypokalaemia, renal dysfunction, hypoalbumina-
emia and the use of mannitol and sodium bicarbonate (17).
Natraemia > 150 mM/L was associated with an almost fivefold
increase in mortality rate (48% vs. 10%). Interestingly, fluid
balance was positive in 384% of patients. We were unable to
estimate fluid balance in our database because, although 24-h
urine output was collected on the study day, fluid intake was
not collected.
Data regarding the incidence and the prognostic value of
hyponatraemia on admission compared with during the ICU
stay are scarcer. In our series, the crude hospital mortality of
patients with hyponatraemia was similar in the two groups.
The difference in the incidence of hyponatraemia between
newly admitted patients and patients already on the ICU
(123% vs 131% respectively) was lower than for hypernatra-
emia (131% vs. 171%, respectively). In their study on the
epidemiology of ICU-acquired dysnatraemia, Stelfox et al. [8]
reported a higher incidence of ICU-acquired hypernatraemia
(26%) than of ICU-acquired hyponatraemia (11%), but these
authors included serum sodium values of 133 and 134 mM/L
in their normal range. In contrast, using a threshold of
135 mM/L to define hyponatraemia, Sakr et al. [15] found a
higher incidence of ICU-acquired hyponatraemia (136%) than
ICU-acquired hypernatraemia (91%) in a series of about
11 000 surgical ICU patients. In our series, dysnatraemia
observed in patients already in the ICU on the study day
cannot be strictly considered as ICU-acquired dysnatraemia as
the condition may has already been present prior to ICU
admission. This represents a limitation to the comparison with
other series and in particular that of Sakr et al. [15], in which
dysnatraemia at ICU admission was associated with a higher
risk of in-hospital death, compared with ICU-acquired dy-
snatraemia. In our study, hospital mortality was not statisti-
cally different in patients with dysnatraemia admitted in the
ICU on the study day than in those already present in the ICU
on the study day, although there a was a tendency towards a
lower mortality in this latter group.
Our study documented the U-shaped pattern of mortality
described in earlier studies of ICU and non-ICU populations
[4–7], with greater mortality rates at the extreme values of both
hypo- and hypernatraemia. Interestingly, the only adjusted OR
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was that of patients already in the ICU who had severe hyp-
onatraemia, an observation also made in the series by Funk
et al. [4]. The association between dysnatraemia and mortality
was present in infected and noninfected patients, but was not
different between these groups. Waikar et al. [6] studied the
influence of hyponatraemia on in-hospital, 1-year and 5-years
mortality rates in a large population of more than 98 000
unselected adult patients. Although these authors observed a
close relationship between hyponatraemia – even when mild –
and hospital mortality, mortality was not increased in patients
with septic hyponatraemia, for any degree of hyponatraemia.
However, their population was not an ICU cohort, which
suggests a difference in the degree of severity of sepsis and
organ dysfunctions.
This study has several strengths and limitations. The EPIC II
study was a multicentre worldwide cohort. The strength of a
point prevalence study is to eliminate any variability in treat-
ments that may occur over the years, as has been the case in
some other studies [4,7]. In particular, intravenous fluid dose
and composition have changed over the years as individualized
goal-directed fluid therapy has become more common [20]. The
limitation of a point prevalence study is the lack of information
about the time course of these abnormalities and factors that
may have contributed to the development of dysnatraemia
during the ICU stay. In addition, we did not collect data on
therapeutic decisions likely to influence natraemia, such as the
nature and amount of fluid administered or other forms of
treatment, including diuretics or vasopressin derivatives.
Another potential limitation is that the data were obtained
several years ago; nevertheless, although there have been some
changes in the overall management of critically ill patients
during that time, the treatment of dysnatraemia has not chan-
ged much. Finally, the prognostic value of dysnatraemia in ICU
patients does not necessarily imply a cause-and-effect rela-
tionship; rather dysnatraemia may be a surrogate marker for
severity of underlying disease. Nevertheless, dysnatraemia and
associated conditions probably act as additive mechanisms
leading to death. This possible mechanism has also been sug-
gested by Hoorn et al. [21] in a recent review on hyponatraemia
and mortality: the underlying disease causes hyponatraemia
and contributes to mortality, but hyponatraemia further
increases this mortality risk.
In conclusion, we have shown that dysnatraemia in the ICU
is an independent predictor of increased hospital mortality,
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Figure 3 Adjusted odds ratios for hospital mortality in
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Figure 2 Adjusted odds ratios for hospital mortality among
the different categories of natraemia.
Figure 1 Crude hospital mortality in the different categories
of natraemia.
938 ª 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
F. VANDERGHEYNST ET AL. www.ejci-online.com
the dysnatraemia is recorded (at admission or during the ICU
stay). There is a clear U-shaped relationship between the
severity of the hypo- and hypernatraemia and mortality
(in other words a ‘dose–response effect’). This link between
dysnatraemia and mortality supports the need for a prospec-
tive, controlled trial to investigate the impact of tight natraemic
control on outcome. A challenge for such a trial would be to
elaborate a therapeutic algorithm for the correction of dysna-
traemia.
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Appendix
List of participating centres by country,
alphabetically
Andorra: Hospital Nostra Senyora de Meritxell (A. Margarit);
Argentina: Centro de Educacion Medica E Investigaciones
Clınicas (R. Valentini); Clinica de Especialidades Villa Maria
(A. J. Zazu); Clınica Modelo de Moron (C. Bevilacqua); Clinica
Y Maternidad Suizo (M. Curone); CMIC (R. Rabuffetti);
Hospital Aleman (P. Comignani); Hospital Argerich (M. Torres
Boden); Hospital Britanico (F. Chertcoff); Hospital Central de
San Isidro (G. Cardonatti); Hospital de Ni~nos Dr. Hector
Quintana (F. Aden); Hospital del Ni~no Jesus (L. Marcos);
Hospital Dr Pedro Ecay (M. Donofrio); Hospital Espa~nol de
Mendoza (R. Fernandez); Hospital Espa~nol Medical Plaza
(R. Lamberghini); Hospital Internacional General de Agudos ‘Jose
de San Matın’ (S. Balasini); Hospital Interzonal Dr. O.Alende
(J. Teves); Hospital Italiano de Buenos Aires (M. Las Heras,
J Sinner); Hospital Juan A. Fernandez (D. Ceraso); Hospital
Municipal de Chivilcoy (D. Curcio); Hospital Profesor Alejan-
dro Posadas (L. Aguilar); Hospital Provincial de Rosario
(C. Weller); Hospital Provincial del Centenario (L. Cardonnet);
Hospital Regional Rio Gallegos (R. Santa Cruz); Hospital
Regional Ushuaia (E. Manrique); Hospital Universitario Austral
(D. Bernardez, T. Iolster); Hospital Universitario Universidad
Abierta Interamericana (G. Chiappero); Instituto Privado del
Quemado Med-Inter (D. Curcio); Nuevo Hospital El Milagro (P.
Ramos); Ramos Mejia Hospital (J. Vergara); Sanatorio Agote (I.
Moine); Sanatorio de la Trinidad Mitre (S. Ilutovich); Sanatorio
de Los Arcos (G. Jannello); Sanatorio Dupuytren (M.Waschbusch);
Sanatorio Frangioli de Salud 2000 Srl (G. Rios Picaza); Sanatorio
Mater Dei (A. Raimondi); Sanatorio Otamendi Y Miroli (M.
Miriam); Sanatorio Parque (L. Carlos); Sanatorio San Jose (D.
Curcio); Armenia: Centro Gallego de Buenos Aires (M. Caridi);
Australia: Alfred Hospital (T. Leong); Barwon Health
(N. Orford); Blacktown Hospital (G. Reece); Box Hill Hospital
(D. Ernest); Cabrini Hospital (F. Hawker); Concord Repatria-
tion General Hospital (J. Tan); Epworth Eastern Private
Hospital (C. Giannellis); Epworth Hospital Richmond (B. Ihle);
Flinders Medical Centre (A. Bersten); Frankston Hospital
(J. McInnes); Gold Coast Hospital (M. Tallott); John Hunter
Hospital (B. Mcfadyen); Joondalup Health Campus (J. Vibert);
Liverpool Hospital, Sydney South West Area Health Service
(M. Parr); Logan Hospital (K. Tran); Mater Health Services
(J. Sutton); Mount Hospital (S. Webb); Nambour General Hos-
pital (N. Groves); Nepean Hospital, NSW (L. Cole); Prince
Charles Hospital (D. Long); Prince of Wales Hospital (F. Bass);
Princess Margaret Hospital For Children (S. Erickson); Royal
Brisbane and Womens’ Hospital (J. Lipman); Royal Children’s
Hospital, Brisbane (D. Long); Royal Children’s Hospital,
Melbourne (C. Delzoppo); Royal Darwin Hospital (J. Thomas);
Royal Perth Hospital (G. Dobb); Royal Prince Alfred Hospital
(M. Daley); Sir Charles Gairdner Hospital (B. Roberts); St John
of God Hospital, Subiaco (S. Webb); St Vincent’s Hospital,
Melbourne (J. Santamaria); Sydney Children’s Hospital
(J. Young); The Children’s Hospital at Westmead, Sydney
(M. Festa); The John Flynn Private Hospital (R. Holland); The
Prince Charles Hospital (D. Mullany); The Queen Elizabeth
Hospital (P. Williams); The Townsville Hospital (M. Corkeron);
The Wollongong Hospital (M. Gales); Westmead Hospital
(A. Banerjee); Women’s and Children’s Hospital, Adelaide
(M. Yung); Austria: University Hospital Innsbruck (N. Mutz,
M. Hiesmayr); General Hospital (P. Faybik); Hospital Hietzing
(R. Fitzgerald); Krankenhaus Barmherzige Br€uder Linz
(F. Firlinger); Krankenhaus Der Barmherigen Brueder Wien
(G. Zasmeta); Krankenhaus Der Barmherzigen Br€uder St. Veit
(M. Zink); Krankenhaus Der Barmherzigen Schwestern Linz
(W. Sieber); Krankenhaus Steyr (J. Hildegard); Landeskran-
kenhaus Klagenfurt (R. Bakondy); Landeskrankenhaus
Stolzalpe (J. Schlieber); Landeskrankenhaus Deutschlandsberg
(G. Filzwieser); Medical University Innsbruck (R. Beer,
M. Joannidis); Medical University of Vienna (T. Staudinger);
Otto-Wagner Hospital (R. Schuster); Unfallkrankenhaus
Meidling Der Auva (W. Scherzer); University Hospital
(K. Smolle); Wilhelminenspital (S. Fitzal); Bangladesh: Central
Hospital Limited (R. Manzoor); Belgium: A.I.T. (J. Brunain);
Ambroise Pare (A. Dive); Asz-Aalst (G. Huylenbroeck); Az
Groeninge Kortrijk (M. Van der Schueren); Az Maria Middel-
ares (H ‘t kindt); Az Sint Jozef Malle (E. Slock); Az Sint Lucas
(D. Rijckaert); Az St Augustinus (J. Raemaekers); Az St Jan Av
(M. Bourgeois); Az Vesalius (I. Van Cotthem); Az Damiaan
Oostende (G. Nackaerts); C.H.N.D.R.F. (D. Gusu); Centre
Hospitalier de Mouscron (P. Gadisseaux); CH Libramont
(V. Olivier); Chirec – Braine-L’Alleud (H. Lignian); CHPLT
Verviers (P. Michel); CHR Citadelle (V. Fraipont); CHR Haute
Senne Soignies (M. Vander Stappen); CHR St Joseph
Mons-Warquignies (F. Fore^t); CHU Brugmann (D. De Bels,
J. Devriendt, J. Massaut); CHU Charleroi (P. Biston); CHU
Saint-Pierre (A. Roman); CHU Sart Tilman, Liege (B. Lamber-
mont); Clinique Sainte Elisabeth (A. De Meulder); Clinique
Notre Dame (V. Frederic); Clinique Notre-Dame de Gra^ce
(T. Sottiaux); Clinique Saint Luc, Bouge (P. Ruyffelaere);
Cliniques de L’Europe, St-Michel (V. Collin); Cliniques de
L’Europe, Ste Elisabeth (S. Anane); Ho^pital Francais
(P. Kleiren); Ho^pital Saint-Joseph (M. Simon); Hornu (S.
Machayekhi); Imeldaziekenhuis (E. Frans); Institut Jules Bordet
(G. Leroy, T. Berghmans); Jan Yperman Hospital (R. Joseph);
Olv Ter Linden Ziekenhuis, Knokke (J. Eerens); Saint Luc
University Hospital (P. F. Laterre); Sint Augustinus, Veurne (B.
Lagrou); St Vincent (R. Rutsaert); St-Jozefkliniek Bornem-
Willebroek (W. Pisarek); UCL Mont-Godinne (A. Dive);
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Universitair Ziekenhuis Gent (J. De Waele); University Hospital
Brussels (H. Spapen); University Hospital of Liege (P. Damas);
Erasme University Hospital (J. L. Vincent); ZNA Stuivenberg
(M. Malbrain); Belize: Universal Health Services, Medical
Center (J. Hidalgo); Brazil: Bandeirantes Hospital (M. Baptista);
Barra Dor Hospital (D. Salgado); Biocor Instituto (M. Braga);
Casa de Saude Sao Jose Caxias (C. Avila); Centro Hospitalar
Unimed (G. Westphal); Centro Integrado de Atenca~o A Saude
-Unimed Vitoria (E. Caser); Clınica S~ao Vicente da Gavea
(A. Alves); Complexo Hospitalar Santa Casa de Porto Alegre
(G. Friedman); Erasto Gaertner Hospital (M. Luz); Federal
University of Sao Paulo (M. Assuncao); Fundacao Hospital de
Clinicas Gaspar Vianna (H. Reis); Fundac~ao Hospitalar Do
Estado de Minas Gerais – Fhemig (A. Gomes); Fundac~ao Pio Xii
(U. Silva); UNIFESP (W. Nogueira Fh); Hopital das Clınicas –
FMUSP (S. El-Dash); Hospital Padre Albino-Faculdade de
Medicina de Catanduva (J. Valiatti); Hospital Alberto
Cavalcanti (A. Barbosa); Hospital Badim (C. Coelho); Hospital
Cardiotrauma Ipanema (M. Knibel); Hospital Carlos Fernando
Malzoni (C. Minelli); Hospital Da Cidade de Passo Fundo
(J. Caovilla); Hospital das Clınicas da Faculdade de Medicina
de Ribeir~ao Preto da Universidade de S~ao Paulo (G. Teixeira);
Hospital das Clınicas, Universisty of S~ao Paulo (A. Hovnanian);
Hospital das Nacoes (A. Rea-Neto); Hospital de Base-Famerp
(S. L. Lobo); Hospital de Clınicas Mario Lioni (M. Lugarinho);
Hospital de Clınicas Niteroi (P. Souza); Hospital de Doencas
Tropicais de Goia^nia (D. Ferreira); Hospital do Cancer/
Uopeccan (P. Duarte); Hospital do Trabalhador (M. Oliveira);
Hospital dos Servidores do Estado Rio de Janeiro (J. Marques);
Hospital E Maternidade S~ao Jose (R. Machado); Hospital Esta-
dual Diadema (P. Rehder); Hospital Estadual do Grajau-Unisa
(S. Mataloun); Hospital Evangelico (M. Grilo); Hospital
Evangelico do Rio de Janeiro (P. Quesado); Hospital Geral de
Pedreira (M. Moock); Hospital Geral de S~ao Mateus
(F. Ferreira); Hospital Geral Roberto Santos (J. Teles); Hospital
Israelita Albert Einstein (E. Silva); Hospital Israelita Albert
Sabin (C. Coelho); Hospital Julia Kubitschek (A. Morais);
Hospital Mater Dei (F. Carvalho); Hospital Memorial Arthur
Ramos (M. Wanderley); Hospital Meridional (M. Velasco);
Hospital Moinhos de Vento (N. Brand~ao da Silva); Hospital
Municipal S~ao Jose (J. Feijo); Hospital Nossa Senhora Da Salete
(P. Duarte); Hospital Pasteur (V. Souza Dantas); Hospital
Portugue^s (J. Teles); Hospital Pro-Cardıaco (R. Costa Filho);
Hospital Quinta D’Or (A. Japiassu); Hospital Regional Anto^nio
Dias (D. Villela); Hospital Regional de Barbacena (C. Santos);
Hospital Salvador (R. Passos); Hospital Samaritano (R. Alheira-
Rocha); Hospital Santa Izabel (R. Silva); Hospital Santa Paula (J.
Houly); Hospital Sao Cristovao (J. Aldrighi); Hospital S~ao
Lucas (R. Hatum); Hospital S~ao Lucas da PUCRS (F. Suparregui
Dias); Hospital S~ao Luiz – Unidade Itaim (L. Ferreira); Hospital
S~ao Rafael (L. Ferro); Hospital S~ao Vicente de Paulo (J. Gomez);
Hospital Universitario Clementindo Fraga Filho – Ufrj (R. Fle-
ury); Hospital Universitario da Universidade Federal do Rio de
Janeiro (C. David); Hospital Universitario de Santa Maria
(T. Resener); Hospital Universitario do Oeste do Parana
(P. Duarte); Hospital Universitario Lauro Wanderley – UTI
Adulto (C. Mendes); Hospital Universitario Regional de
Maringa (A. Germano); Hospital Vita Curitiba (M. Oliveira);
Hospital Vivalle (F. De marco); Instituto de Espquisa Clinica
Evandro Chagas (A. Japiassu); Instituto Do Corac~ao – HC-
FMUSP (S. Lage); Instituto Nacional de Cancer (J. Salluh);
Irmandade Santa Casa de Misericordia de Porto Alegre
(A. Torelly); Luxemburgo Hospital (R. Sad); Mternidade Odete
Valadares (A. Barbosa); Prontocor Lagoa (G. Oliveira); Samar-
itano Hospital (R. Lima); Santa Casa Da Misericordia de S~ao
Jo~ao del Rei (J. Paranhos); Santa Casa de Misericordia de Passos
(M. Oliveira); Santa Casa de Porto Alegre (M. Rocha); S~ao
Sebasti~ao Hospital (W. Bitencourt); Universidade Federal Do
Parana (A. Rea-Neto); University of Londrina (C. Grion);
University of Sao Paulo (D. Forte); Uti Da Disciplina de Clınica
Medica-Unifesp (H. Guimar~aes); Vitoria Apart Hospital
(C. Piras); Bulgaria: Mbal Ruse (L. Stephanova); Multiprofile
Hospital of Active Treatment, Ruse (L. Lyubenov); Uh St. Ek-
aterina (G. Tsarianski); Univerisity Hospital (G. Dimov); Can-
ada: Capital Health-Queen Elizabeth II Health Sciences Centre
(R. Green); Centre Hospitalier Regional de Lanaudiere
(J. Levasseur); Children’s Hospital of Eastern Ontario (R.
Ward); CHU Sherbrooke (O. Lesur); Ho^pital Charles Lemoyne
(G. Poirier); Mount Sinai Hospital (R. Wax); Royal Jubilee
Hospital (G. Wood); St. Joseph’s Healthcare (D. Cook); St.
Michael’s Hospital (J. Marshall); Toronto General Hospital
(M. Herridge); Toronto Western Hospital (N. Ferguson);
Victoria General Hospital (G. Wood); Chile: Clinica Alemana de
Santiago (M. Espinoza); Clinica las Condes (S. Valdes jimenez);
Hospital Clınico de la Pontificia Universidad Catolica de Chile
(A. Bruhn); Hospital del Trabajador (J. Micolich); Hospital Dr
G. Fricke (S. Galvez); Hospital El Pino (I. Escamilla Leon);
China: Beijing Chaoyang Hospital (Q. Zhan); Beijing Tongren
Hospital (Y. Xu); Chinense Pla General Hospital (Y. Zhao);
Fuxing Hospital, Capital Medical University (L. Zhang);
Guangdong Provincial People’s Hospital (T. Qin); Peking
Union Medical College Hospital (B. Du); Peking University
People’s Hospital (M. Li); Ren Ji Hospital,Shanghai Jiao Tong
University (X. Wang); The Affiliated Hospital of Ningxia
Medical College of China (Y. Jing); The First Affiliate Hospital
of China Medical University (Z. Zhang); The First Affiliated
Hospital of Dalian Medical University (W. Xianyao); The First
People’s Hospital of Nantong, Jiangsu (F. Li); Zhong-Da Hos-
pital and School of Clinical Medicine, Southeast University (Y.
Congshan); Colombia: Clinica General del Norte (C. Rebolle-
do); Clinica Central del Quindio (D. Diaz); Clinica Medellin (R.
Murillo Arboleda); Clinica Saludcoop (C. Rebolledo); Clinica
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Santa Isabel de Valledupar. (A. Arias Antun); Fundacion
Hospital San Carlos (G. Montenegro); Fundacion Valle del Lili
(M. Granados); Hospital Bocagrande de Cartagena (C. Duenas);
Hospital Departamental de Villavicencio (N. Perez); Hospital El
Tunal (G. Libreros Duque); Hospital San Jose de Bogota (M.
Coral); Hospital Santa Clara (G. Ortiz); Costa Rica: Hospital
Calderon Guardia CCSS (D. Rodriguez); Croatia: Hospital for
Infectious Diseases (B. Barsic); Sveti Duh General Hospital,
School of Medicine, Zagreb (M. Cubrilo-Turek); University
Hospital Centre (I. Gornik); University Hospital Zagreb (M.
Grljusic); Cuba: Hospital Universitario Arnaldo Milian Castro
(A. Caballero lopez); Hospital Universitario Dr. Gustavo Al-
dereguıa Lima (M. Iraola ferrer); Czech Republic: Centre of
Cardivascular and Transplant Surgery (P. Pavlik); Charles
University Teaching Hospital, Hradec Kralove (J. Manak);
Charles University Medical School and Teaching Hospital (J.
Radej); Faculty General Hospital, Charles University Prague (J.
Belohlavek); Faculty Hospital Brno (P. Sevcik); Faculty Hospital
Olomouc (L. Blahut); General Teaching Hospital of 1St Faculty
and Charles University (D. Tyl); Horovice Hospital (J. Stein-
bach); Klaudians Hospital (I. Herold); Krajska Nemocnice
Liberec (I. Zykova); Nemocnice V Usti Nad Orlici (D. Prchal);
St. Anne’s University Hospital Brno (T. Bartosik); University
Hospital Brno (M. Kolarova); University Hospital Olomouc
(R. Hajek, J. Kohoutova, O. Marek); University Hospital
Ostrava (P. Hon); University Hospital Plzen (I. Chytra);
Denmark: Arhus University Hospital (H. Betsch); Næstved
Hospital (B. Fogh); Rigshospitalet (K. Espersen); Sygehus Fyn
(K. Jacobsen); Vejle Sygehus (P. Berezowicz); Ecuador: Carlos
Andrade Marın Hospital (F. Guerrero); Clinica La Merced
(E. Salgado); Hospital Eugenio Espejo (D. Barahona); Hospital
General de Las Fuerzas Armadas del Ecuador Hg-1 (H. Del
pozo sanchez); Hospital Metropolitano (M. Jibaja); Egypt: Dar
Alfouad Hospital (A. Alansary); Estonia: East Tallinn Central
Hospital (A. Reintam); Tartu University Hospital (J. Starkopf);
Finland: Helsinki University Central Hospital (V. Harjola);
France: AP-HP, CHU Jean Verdier (L. Tual); Assistance
Publique-Ho^pitaux de Marseille, CHU Nord (M. Leone); Centre
Hospitalier Dunkerque (M. Serge); Centre Hospitalier
Universitaire (P. Michel); Centre Hospitalier (O. Leroy); Centre
Hospitalier D’Auch (L. Mallet); Centre Hospitalier de Blois
(B. Marc); Centre Hospitalier de Fougeres (D. Dormoy); Centre
Hospitalier de Niort (H. Pascal); Centre Hospitalier Dr
Schaffner (L. Tronchon); Centre Hospitalier du Pays D’Aix
(B. Garrigues); Centre Hospitalier Region Annecy (C. Santre);
Centre Hospitalier Universitaire Amiens (H. Dupont); Centre
Hospitalier Universitaire de Bice^tre (J. Duranteau); Centre
Hospitalier Universitaire Reims (A. Leon); CH Colmar (L.
Henry); CHG Armentieres (C. Canevet); CHU Angers (L.
Dube); CHU Angers (H. Julien); CHU Bicetre (A. Nadia); CHU
Brest (B. Francois); CHU de Bordeaux (J. Gerard); CHU Dijon
Hopital General (M. Freysz); CHU Ho^tel Dieu – APHP (G.
Remy); CHU Nantes (Y. Blanloeil); Clinique Ambroise Pare (P.
Squara); General Hospital (J. Korach); Grenoble University
Hospital (M Durand); Groupe Hospitalier du Havre (C. Gab-
riel); Hia Laveran (P Eric); Hopital Antoine Beclere APHP (F.
Jacobs); Hopital Bichat (R. Bronchard); Ho^pital Claude Huriez,
Centre Hospitalier Regional Universitaire de Lille (E. Kipnis);
Hopital Cochin Paris (M. Moussa); Ho^pital de Hautepierre
(A. Launoy); Hopital de la Croix Rousse (C. Guerin); Ho^pital
Edouard Herriot (P. Vanhems); Ho^pital Maison Blanche
(A. Wynckel); Ho^pital Raymond Poincare (B. Clair); Ho^pital
Saint-Louis (E. Azoulay); Ho^pital Tenon (J. Fulgencio);
Ho^pitaux Civils de Colmar (Y. Gottwalles); Ho^pitaux
Universitaires de Strasbourg (T. Krummel); Hospices Civils de
Lyon (A. Lepape); La Rochelle Hospital (O. Lesieur);
Lariboisiere University Hospital (D. Payen); Poissy Hospital (O.
Herve); Polyclinique Saint Andre (J Farkas); Rangueil Hospital
(P. Cougot); Reanimation Chirurgicale (Y. Malledant); Univer-
sity Hospital of Bordeaux Haut-Leveque (O. Joannes-Boyau);
Germany: Academic Hospital Solingen (T. Standl); Ameos
Klinikum St.Salvator Halberstadt GMBH (U. Sierig); Asklepios
Fachkliniken M€unchen-Gauting (J. Geiseler); Asklepios Klinik
Langen (H. Hopf); Behandlungszentrum Vogtareuth (M. Bur-
gau); Bergmannsheil Bochum (E. Conrad-Opel); Bethanien-
Krankenhaus (C. Hermann); Bundeswehrkrankenhaus Ulm (M.
Ventzke); Charite/Campus Virchow-Klinikum (T. Henneberg);
Charite Berlin-Buch (H. Loeser); Charite Campus, Mitte
(C. Spies); Charite Campus, Virchow Klinikum (C. Spies);
Charite Campus, Virchow (F. Esposito); Charite Univer-
sit€atsmedizin Berlin (H. Zuckermann-becker); Clemenshospitl
(R. Scherer); Dominikus Krankenhaus (A. Pauer); Drk-Kliniken
Mark Brandenburg (S. Kljucar); Drk-Krankenhaus Ratzeburg
(K. Delfs); Elisabeth-Krankenhaus Essen (E. Blank); Ev.
Kliniken Bonn Betriebsst€atte Waldkrankenhaus (J. Busch);
Ev.-Freikirchliches Krankenhaus R€udersdorf (K. Wendt);
Evang. Krankenhaus M€ulheim (J. Leßmann); Evangelische
Kliniken Bonn Wadkrankenhaus (J. Busch); Evangelisches
Krankenhaus Bielefeld (F. Bach); Friedrich Schiller University,
Jena (Y. Sakr); Gemeinschaftskrankenhaus Herdecke (T. Berlet);
Georg-August University of G€ottingen (A. Kernchen); Georg-
August-University of G€ottingen (M. Quintel); Hanse-Klinikum
Wismar (D. Holst); Heart clinic of the University of Munich
(E. Kilger); Helfenstein Klinik (T. Holubarsch); Helios Klinik
Lengerich (C. Raufhake); Helios-Klinikum Berlin-Buch
(R. Kuhlen, C. Stolt); Helios Klinikum Emil Von Behring (A.
Lubasch); Helios Klinikum Erfurt Gmbh (A. Meier-Hellmann);
Helios Klinikum Wuppertal Barmen (G. Woebker); Henriet-
tenstift (C. Scharnofske); Herz-Jesu-Krankenhaus (M. Breyer);
Hochtaunus Kliniken Bad Homburg (T. Risch); Hospital Links
Der Weser (C. Manhold); Icu In Drk Kliniken Mark Branden-
burg (S. Kljucar); J.W. Goethe – University Medical School
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Frankfurt Am Main (D. Meininger); Johanniter Krankenhaus
Bonn (C. Greive); Johanniter Krankenhaus Stendal Ggmbh
(J. Rau); Jung-Stilling-Krankenhaus (A. Seibel); Katharinenhos-
pital (A. Henn-beilharz); Katholisches Krankenhaus Hagen
(R. Wolbert); Krankenhaus Prignitz Gemmeinn€utzige GMBH
(T. Scherke); Klinik Am Eichert (J. Martin); Klinik F€ur Her-
zchirurgie (M. Rudolph); Klinik F€uran€asthesie, Operative
Intensivmedizin U. Schmerztherapie (J. Gleißner); Kliniken
Ludwigsburg-Bietigheim GMBH (M. Wolf); Kliniken Maria
Hilf (F. Schleibach); Klinikum Augsburg (U. Jaschinski);
Klinikum Bad Salzungen (A. Lunkeit); Klinikum Darmstadt
(M. Welte); Klinikum Der J.W. Goethe-Universit€at (T. Bingold);
Klinikum Der Stadt Wolfsburg (K. Sydow); Klinikum Emden
(K. Kogelmann); Klinikum Forchheim (F. Fischer); Klinikum
Fuerth (B. Fischer, M. Schmid); Klinikum Grosshadern, Uni-
versit€at M€unchen (M. Klein); Klinikum Harlaching St€adtisches
Klinikum Muenchen (A. Bechtold); Klinikum Hildesheim
(K. Bodmann); Klinikum Kaufbeuren (J. Klasen); Klinikum
Landsberg (H. Meyrl); Klinikum Lippe – Detmold (J. Goetz);
Klinikum Ludwigsburg (G. Geldner); Klinikum Luedenscheid
(T. Helmes); KlinikumMeiningen GMBH (N. Jensen); Klinikum
Minden (H. Eickmeyer, W. Lengfelder); Klinikum N€urnberg
(B. Langenstein); Klinikum Rechts Der Isar (R. Bogdanski);
Klinikum Rechts Der Isar Der Technischen Universit€at
M€unchen (S. Jelen-Esselborn, A. Umgelter); Klinikum Region
Hannover (F. D€orr); Klinikum Region Hannover Krankenhaus
Großburgwedel (K. L€uttje); Klinikum Region Hannover,
Krankenhaus Oststadt-Heidehaus (D. Heinemeyer); Klinikum
Starnberg (M. Uhl); Klinikum Stuttgart – Olgahospital (P.
Schirle); Klinikum Suedstadt (H. Benad); Klinikum Traunstein
(M. Glaser); Klinikum Uelzen (W. Panzer); KlinikumWorms (E.
Huettemann); Klinikverbund St. Ansgar, Krankenhaus Bassum
(R. Stierwaldt); Klinikverbund S€ud-West (M. Schappacher);
Knappschaftskrankenhaus Bochum-Langendreer (E. M€uller);
Krankenhaus Freyung (Rural Hospital) (W. Stadlmeyer);
Krankenhaus L€ubbecke (M. Fantini); Krankenhaus Mol GMBH
Strausberg (B. Dummer); Krankenhaus Nordwest (M. Th€orner);
Krankenhaus Nordwest (V. Jost); Krankenhaus Reinbek (T.
Loerbroks); Kreisklinik Trostberg (T. Gl€uck); Kreiskrankenhaus
Bergstrasse (R. Zimmermann); Kreiskrankenhaus Calw (R.
Clement); Kreiskrankenhaus Mechernich GMBH (R. Hering);
Kreiskrankenhaus Nagold (T. Klinger); Kreiskrankenhaus
Rottweil (J. Mehl); Kreiskrankenhaus St. Marienberg Helmstedt
(H. Polozek); Leopoldina-Krankenhaus (A. Rothhammer);
Ludmillenstift (R. Seidler); Lukas-Krankenhaus B€unde
(P. Lorenz); Lungenfachklinik Amsee Waren Mueritz
(M. Lutze); Marienhospital Bruehl (M. Euler); Marienkranken-
haus Schwerte (M. Heintz); Martin Luther Universit€at Halle
(M. Winkler); Medizinische Klinik (M. Angstwurm); Mlu Halle-
Wittenberg (K. Krohe); Mueritz-Klinikum Waren (T. Treu);
Neurological Intensive Care Unit (T. Steiner); Oberschwaben-
klinik Wangen (S. Locher); Orthop€adische Klinik Markgr€onin-
gen (A. Walz); Ostalb-Klinikum Aalen (P. Zahn); Otto-Von-
Guericke Universit€at Magdeburg (W. Brandt); Scivias-Kran-
kenhaus St. Josef (M. Marks); Ska-Bileelfeld-Mitte (F. Henning);
St. Antonius Hospital (U. Janssens); St. Hildegardis Kranken-
haus Mainz (M. Luethgens); St. Johannes Krankenhaus (W.
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